Randomized phase II trial of adjuvant combined epigenetic therapy with 5-azacitidine and entinostat in resected stage I non-small cell lung cancer versus standard of care - Stand Up To Cancer

Blog

Posted October 14, 2019

Randomized phase II trial of adjuvant combined epigenetic therapy with 5-azacitidine and entinostat in resected stage I non-small cell lung cancer versus standard of care

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.